BioXcel Therapeutics (BTAI) IPO Opens Flat
Tweet
Share
E-mailGet Alerts BTAI Hot Sheet
Join SI Premium – FREE
Today's IPO for BioXcel Therapeutics (NASDAQ: BTAI) opened for trading at $11.07 after pricing 5.5 million shares at $11.00.
Barclays, UBS Investment Bank and BMO Capital Markets were lead managers of the offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Entrata (ENT) files for proposed IPO
- Rainier Acquisition prices $75M IPO on Nasdaq
- DeFi Development Corp. plans $20M preferred stock offering
Create E-mail Alert Related Categories
IPOsRelated Entities
UBS, BMO Capital, Barclays, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
